Alterity Therapeutics (ATHE) Short term Debt (2011 - 2015)

Alterity Therapeutics' Short term Debt history runs 5 years deep, the most recent figure standing at $424.62 for Q4 2015.

• On a quarterly basis, Short term Debt fell 99.41% year-over-year to $424.62 in Q4 2015; TTM through Dec 2015 was $424.62, a 99.41% decrease from a year earlier, with the FY2015 full-year figure at $10.05, down 99.99% from the prior year.
• Short term Debt improved to $424.62 in Q4 2015 per ATHE's latest filing, from $9.33 in the prior quarter.
• Across five years, Short term Debt topped out at $1.1 million in Q4 2013 and bottomed at $9.33 in Q2 2015.
• The 5-year median for Short term Debt is $338000.4 (2011), against an average of $400297.1.
• Across the five-year window, Short term Debt surged 154.86% in 2013 and plunged 99.99% in 2015, its largest moves.
• Year by year, Short term Debt stood at $336559.4 in 2011, then surged by 132.82% to $783567.3 in 2012, then jumped by 44.56% to $1.1 million in 2013, then slumped by 93.68% to $71636.4 in 2014, then tumbled by 99.41% to $424.62 in 2015.
• Per Business Quant, the three latest ATHE Short term Debt figures stand at $424.62 (Q4 2015), $9.33 (Q2 2015), and $71636.4 (Q4 2014).